drugset / Trial / NCT02856503

Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors

NCT02856503

Phase 1/2 Withdrawn Eli Avisar, MD
Non-randomizedParallel-groupOpen-labelTreatment

Summary

High-doses of Vitamin D (VD) may be used as targeted therapy against breast cancer. The investigators will assess the effect of high dose VD on the following biomarkers in the breast cancer cells: VDR, estrogen receptor (ER), progesterone receptor (PR), epidermal growth factor receptor 2 (Her2/neu), androgen receptor (AR), as well as epidermal growth factor receptor 1 (EGFR) and Ki-67, as markers of proliferation, and E-cadherin, a marker of invasion and metastasis.

Timeline

Start
2019-01-13
Primary completion
2023-01-31
Completion
2024-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 50000 iu Oral